Ignite Creation Date:
2025-12-25 @ 3:21 AM
Ignite Modification Date:
2026-01-21 @ 9:06 AM
Study NCT ID:
NCT05873205
Status:
RECRUITING
Last Update Posted:
2025-07-29
First Post:
2023-05-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Open-Label, Phase II Trial of Isatuximab for Patients With Refractory Immune Cytopenias After Allogeneic Hematopoietic Cell Transplantation
Sponsor:
Organization: